文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy.

作者信息

Nunes Sandrina, Pires Isabel, Rosa Andreia, Duarte Lilianne, Bernardes Rui, Cunha-Vaz José

机构信息

Association for Innovation and Biomedical Research on Light and Image, University of Coimbra, Coimbra, Portugal.

出版信息

Ophthalmologica. 2009;223(5):292-7. doi: 10.1159/000213639. Epub 2009 Apr 16.


DOI:10.1159/000213639
PMID:19372723
Abstract

PURPOSE: To examine the relationship between microaneurysm turnover (formation rate), using a new semi-automatic method (MA-Tracker) based on color fundus photographs, and diabetic retinopathy (DR) progression to clinically significant macular edema (CSME). METHODS: In total, 113 patients/eyes with nonproliferative DR (NPDR) were followed up every 6 months for 2 years as controls of the DR clinical trials, and by conventional general and ophthalmological care for the next 8 years (over a total of 10 years' follow-up). Microaneurysm turnover for the 2 first years was computed using the MA-Tracker. RESULTS: The 17 patients that developed CSME over the 10 years of follow-up presented a microaneurysm formation rate of 9.2 +/- 18.2 microaneurysms/year (mean +/- SD) during the first 2 years, which was statistically higher than the eyes that did not develop CSME (0.5 +/- 1.2 microaneurysms/year, p < 0.001). These 17 patients also presented higher HbA(1C) levels at baseline (8.5 +/- 1.2%) compared to the patients who did not develop CSME (7.3 +/- 1.2%, p = 0.001). CONCLUSIONS: A high microaneurysm formation rate on color fundus photographs appears to be a good biomarker for DR progression to CSME in type 2 diabetic patients with NPDR.

摘要

相似文献

[1]
Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy.

Ophthalmologica. 2009

[2]
Computer-assisted microaneurysm turnover in the early stages of diabetic retinopathy.

Ophthalmologica. 2009

[3]
Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.

Invest Ophthalmol Vis Sci. 2007-9

[4]
Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.

Invest Ophthalmol Vis Sci. 2013-7-10

[5]
Web-based grading of compressed stereoscopic digital photography versus standard slide film photography for the diagnosis of diabetic retinopathy.

Ophthalmology. 2007-9

[6]
Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.

Graefes Arch Clin Exp Ophthalmol. 2002-9

[7]
Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.

Diabetes Care. 2012-11-30

[8]
Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.

Retina. 2014-1

[9]
Retinal microaneurysm counts and 10-year progression of diabetic retinopathy.

Arch Ophthalmol. 1995-11

[10]
Enhanced depth imaging optical coherence tomography in type 2 diabetes.

Invest Ophthalmol Vis Sci. 2012-9-7

引用本文的文献

[1]
Comparison of the Usefulness of Optical Coherence Tomography Angiography and Fluorescein Angiography in the Diagnosis of Diabetic Macular Edema.

Diagnostics (Basel). 2025-7-25

[2]
Microvascular Metrics on Diabetic Retinopathy Severity: Analysis of Diabetic Eye Images from Real-World Data.

Biomedicines. 2024-12-2

[3]
Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study.

Ophthalmol Sci. 2024-10-16

[4]
Intraretinal Microvascular Abnormalities in Eyes with Advanced Stages of Nonproliferative Diabetic Retinopathy: Comparison Between UWF-FFA, CFP, and OCTA-The RICHARD Study.

Ophthalmol Ther. 2024-12

[5]
Distribution of Microaneurysms and Hemorrhages in Accordance with the Grading of Diabetic Retinopathy in Type Diabetes Patients.

Diagnostics (Basel). 2024-7-17

[6]
Patterns of Progression of Nonproliferative Diabetic Retinopathy Using Non-Invasive Imaging.

Transl Vis Sci Technol. 2024-5-1

[7]
Referable Diabetic Retinopathy Prediction Algorithm Applied to a Population of 120,389 Type 2 Diabetics over 11 Years Follow-Up.

Diagnostics (Basel). 2024-4-17

[8]
Quantification of Microvascular Lesions in the Central Retinal Field: Could It Predict the Severity of Diabetic Retinopathy?

J Clin Med. 2023-6-9

[9]
Predictive Assessment of Quantitative Ultra-Widefield Angiographic Features for Future Need for Anti-VEGF Therapy in Diabetic Eye Disease.

J Pers Med. 2022-4-10

[10]
Fluorescein Leakage and Optical Coherence Tomography Angiography Features of Microaneurysms in Diabetic Retinopathy.

J Diabetes Res. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索